3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Sarcoma
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Cardiotoxicity
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
pembrolizumab
3
Nivolumab
3
Ifosfamide
3
Doxorubicin
3
AZD 6244
3
selinexor
2
pazopanib
2
fludarabine phosphate
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
tazemetostat
1
metarrestin
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Injections
1
Etoposide
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Dexrazoxane
×
1 year
×
Clear all
No trials found.